|
Volumn 101, Issue SUPPL. 3, 2008, Pages 2-6
|
The concept of neurogenic inflammation
|
Author keywords
1 adrenoceptor antagonists; Alfuzosin; Lower urinary tract symptoms; Neurogenic inflammation; TRPA1; TRPV1
|
Indexed keywords
3 [3,5 BIS(TRIFLUOROMETHYL)BENZYLOXY] 2 PHENYLPIPERIDINE;
ACROLEIN;
ALFUZOSIN;
ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT;
BETA TUBULIN;
CALCITONIN GENE RELATED PEPTIDE;
CAMPHOR;
CAPSAICIN;
CYCLOPHOSPHAMIDE;
NEUROPEPTIDE;
RUTHENIUM RED;
SUBSTANCE P;
TRANSIENT RECEPTOR POTENTIAL CHANNEL;
TRANSIENT RECEPTOR POTENTIAL CHANNEL A1;
UNCLASSIFIED DRUG;
VANILLOID RECEPTOR 1;
DESENSITIZATION;
DISEASE MODEL;
DRUG MECHANISM;
HUMAN;
LOWER URINARY TRACT SYMPTOM;
NERVE ENDING;
NEUROGENIC INFLAMMATION;
NOCICEPTION;
NONHUMAN;
ONCOGENE C FOS;
PRIORITY JOURNAL;
PROTEIN EXPRESSION;
REVIEW;
SENSORY NERVE CELL;
ADRENERGIC ALPHA-ANTAGONISTS;
ANIMALS;
CALCIUM CHANNELS;
HUMANS;
MALE;
NERVE TISSUE PROTEINS;
NEUROGENIC INFLAMMATION;
PROSTATISM;
PROSTATITIS;
QUINAZOLINES;
RATS;
TRANSIENT RECEPTOR POTENTIAL CHANNELS;
TRPV CATION CHANNELS;
URINARY BLADDER;
URINARY BLADDER, OVERACTIVE;
|
EID: 40149100186
PISSN: 14655101
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1464-410X.2008.07493.x Document Type: Review |
Times cited : (202)
|
References (24)
|